Nava I - Search Results

1

Activin Receptor-Ligand Trap for the Treatment of β-thalassemia: A Serendipitous Discovery.

Brancaleoni V, Nava I, Delbini P, Duca L, Motta I. Brancaleoni V, et al. Among authors: nava i. Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020075. doi: 10.4084/MJHID.2020.075. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 33194149 Free PMC article. Review.

2

Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis.

Fiorelli G, De Feo TM, Duca L, Tavazzi D, Nava I, Fargion S, Cappellini MD. Fiorelli G, et al. Among authors: nava i. Eur J Clin Invest. 2002 Mar;32 Suppl 1:21-7. doi: 10.1046/j.1365-2362.2002.0320s1021.x. Eur J Clin Invest. 2002. PMID: 11886428

3

Oxidative status and malondialdehyde in beta-thalassaemia patients.

Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G, Cappellini MD. Cighetti G, et al. Among authors: nava i. Eur J Clin Invest. 2002 Mar;32 Suppl 1:55-60. doi: 10.1046/j.1365-2362.2002.0320s1055.x. Eur J Clin Invest. 2002. PMID: 11886433

4

Changes in erythropoiesis, iron metabolism and oxidative stress after half-marathon.

Duca L, Da Ponte A, Cozzi M, Carbone A, Pomati M, Nava I, Cappellini MD, Fiorelli G. Duca L, et al. Among authors: nava i. Intern Emerg Med. 2006;1(1):30-4. doi: 10.1007/BF02934717. Intern Emerg Med. 2006. PMID: 16941810

5

Gene symbol: G6PD. Disease: Glucose-6-phosphate dehydrogenase deficiency.

Delbini P, Duca L, Nava I, Tavazzi D, Cappellini MD. Delbini P, et al. Among authors: nava i. Hum Genet. 2008 Oct;124(3):312-3. Hum Genet. 2008. PMID: 18846656 No abstract available.

6

Gene symbol: HAMP. Disease: Haemochromatosis, juvenile.

Delbini P, Duca L, Nava I, Meo A, Cappellini MD. Delbini P, et al. Among authors: nava i. Hum Genet. 2008 Oct;124(3):313. Hum Genet. 2008. PMID: 18846657 No abstract available.

7

Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.

Duca L, Delbini P, Nava I, Vaja V, Fiorelli G, Cappellini MD. Duca L, et al. Among authors: nava i. Am J Hematol. 2009 Sep;84(9):592-3. doi: 10.1002/ajh.21465. Am J Hematol. 2009. PMID: 19610021 Free article.

8

Hepcidin mutation in a beta-thalassemia major patient with persistent severe iron overload despite chelation therapy.

Duca L, Delbini P, Nava I, Cappellini MD, Meo A. Duca L, et al. Among authors: nava i. Intern Emerg Med. 2010 Feb;5(1):83-5. doi: 10.1007/s11739-009-0306-8. Epub 2009 Sep 12. Intern Emerg Med. 2010. PMID: 19756955 No abstract available.

9

Genetic variability of TMPRSS6 and its association with iron deficiency anaemia.

Delbini P, Vaja V, Graziadei G, Duca L, Nava I, Refaldi C, Cappellini MD. Delbini P, et al. Among authors: nava i. Br J Haematol. 2010 Nov;151(3):281–4. doi: 10.1111/j.1365-2141.2010.08349.x. Br J Haematol. 2010. PMID: 20738301 Free article.

10

Non-transferrin-bound iron and oxidative stress during allogeneic hemopoietic stem cell transplantation in patients with or without iron overload.

Duca L, Cappellini MD, Baronciani D, Pilo F, Targhetta C, Visani G, Nava I, Angelucci E. Duca L, et al. Among authors: nava i. Am J Hematol. 2018 Sep;93(9):E250-E252. doi: 10.1002/ajh.25201. Epub 2018 Aug 9. Am J Hematol. 2018. PMID: 29981284 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters